Анализ влияния структуры замещенных бензодиазепинов на их фармакокинетические свойства

Influence of the structure of substituted benzodiazepines on their pharmacokinetic properties including the bioavailability, half-elimination period, clearance, and volume of distribution in the human organism has been studied. The analysis was performed using the QSAR/QSPR method based on the Simplex representation of molecular structure. Quite adequate models capable of quantitatively describing the structure - pharmacokinetic properties relationship were obtained using the statistical methods of projection onto latent structures and multiple linear regression. Structural factors determining changes in the pharmacokinetic properties of substituted benzodiazepines are established on the basis of obtained models.